CONTROL OF SECONDARY HYPERPARATHYROIDISM DURING LONG-TERM HEMODIALYSIS

被引：0
|
作者：
FURSZYFER, J
GOLDSMITH, RS
JOHNSON, WJ
ARNAUD, CD
机构：
来源：
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1970年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1036 / +
页数：1
相关论文
共 50 条
  • [11] HYPERPARATHYROIDISM IN LONG-TERM HEMODIALYSIS (HD) PATIENTS
    REICHEL, H
    KILBURG, M
    RITZ, E
    KIDNEY INTERNATIONAL, 1992, 41 (02) : 491 - 491
  • [12] Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis
    Keitaro Yokoyama
    Ryutaro Shimazaki
    Masafumi Fukagawa
    Tadao Akizawa
    Scientific Reports, 9
  • [13] Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism
    Shigematsu, Takashi
    Fukagawa, Masafumi
    Yokoyama, Keitaro
    Akiba, Takashi
    Fujii, Akifumi
    Odani, Motoi
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (02) : 426 - 436
  • [14] Long-term effects of small doses of calcitriol in hemodialysis patients with moderate secondary hyperparathyroidism
    Vlassopoulos, D
    Noussias, C
    Revenas, K
    Hadjilouka-Mantaka, A
    Arvanitis, D
    Tzortzis, G
    Hadjiconstantinou, V
    RENAL FAILURE, 1999, 21 (02) : 199 - 207
  • [15] Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism
    Takashi Shigematsu
    Masafumi Fukagawa
    Keitaro Yokoyama
    Takashi Akiba
    Akifumi Fujii
    Motoi Odani
    Tadao Akizawa
    Clinical and Experimental Nephrology, 2018, 22 : 426 - 436
  • [16] Long-Term Efficacy and Safety of Evocalcet in Japanese Patients with Secondary Hyperparathyroidism Receiving Hemodialysis
    Yokoyama, Keitaro
    Shimazaki, Ryutaro
    Fukagawa, Masafumi
    Akizawa, Tadao
    Maeda, Yoshitaka
    Ueki, Kazue
    Fujii, Takayuki
    Miyazaki, Ryoichi
    Azekura, Hisanori
    Kasuga, Hirotake
    Tomiyoshi, Yoshiyuki
    Shinzato, Takeaki
    Iwashita, Ryuji
    Takada, Kenji
    Suda, Akio
    Nagaoka, Takashi
    Yoshimoto, Mitsuru
    Taniguchi, Masatomo
    Ogawa, Hiroshi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [17] A long-term comparative study of calcitriol versus alphacalcidol in patients with secondary hyperparathyroidism on hemodialysis
    Arenas, M. D.
    Muray, S.
    Arnoedo, M. L.
    Egea, J. J.
    Millan, J.
    Gil, M. I.
    NEFROLOGIA, 2006, 26 (02): : 226 - 233
  • [18] Effects of Long-Term Cinacalcet Administration on Parathyroid Gland in Hemodialysis Patients with Secondary Hyperparathyroidism
    Okuno, Senji
    Inaba, Masaaki
    Ishimura, Eiji
    Nakatani, Shinya
    Chou, Hidenori
    Shoji, Shigeichi
    Yamakawa, Tomoyuki
    NEPHRON, 2019, 142 (02) : 106 - 113
  • [19] COMPARABLE LONG-TERM CONTROL OF SECONDARY HYPERPARATHYROIDISM IN UREMIA BY PROPRANOLOL AND ATENOLOL
    MAKDASSI, R
    MORINIERE, P
    COEVOET, B
    GUERIS, J
    CALMETTES, C
    FLOUVAT
    FOURNIER, A
    MINERAL AND ELECTROLYTE METABOLISM, 1981, 6 (4-5) : 252 - 252
  • [20] Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism
    Malberti, F
    Corradi, B
    Cosci, P
    Calliada, F
    Marcelli, D
    Imbasciati, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) : 704 - 712
12345